Literature DB >> 10640587

Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.

S L Law1, K J Huang, C H Chiang.   

Abstract

The in vitro corneal penetration and in vivo corneal absorption of acyclovir from an acyclovir-containing liposome system were investigated. Results of in vitro corneal penetration demonstrated that positively charged liposomes resulted in a penetration rate lower than those of negatively charged liposomes and free acyclovir in solution. An in vivo study indicated that the extent of acyclovir absorption from positively charged liposomes was higher that those from negatively charged liposomes and free acyclovir. The acyclovir concentration in the cornea after administration of positively charged liposomes showed that an acyclovir deposition in the cornea was greater than those of negatively charged liposomes and free acyclovir. From morphological observation of the cornea surface treated with liposomes, it was suggested that positively charged liposomes formed a completely coated layer on the cornea surface. These liposomes would bind intimately on the cornea surface, leading to an increase of residence time. Therefore, positively charged liposomes resulted in an increase of acyclovir (ACV) absorption.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640587     DOI: 10.1016/s0168-3659(99)00192-3

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  33 in total

Review 1.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

2.  Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells.

Authors:  Luís F Neves; Jinghua Duan; Adrienne Voelker; Anil Khanal; Lacey McNally; Jill Steinbach-Rankins; Brian P Ceresa
Journal:  J Microencapsul       Date:  2016-08-10       Impact factor: 3.142

Review 3.  Techniques for physicochemical characterization of nanomaterials.

Authors:  Ping-Chang Lin; Stephen Lin; Paul C Wang; Rajagopalan Sridhar
Journal:  Biotechnol Adv       Date:  2013-11-16       Impact factor: 14.227

4.  Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium.

Authors:  S K Jain; R K Jain; M K Chourasia; A K Jain; K B Chalasani; V Soni; A Jain
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

5.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

Review 6.  Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.

Authors:  Md Habban Akhter; Irfan Ahmad; Mohammad Y Alshahrani; Alhanouf I Al-Harbi; Habibullah Khalilullah; Obaid Afzal; Abdulmalik S A Altamimi; Shehla Nasar Mir Najib Ullah; Abhijeet Ojha; Shahid Karim
Journal:  Gels       Date:  2022-01-28

7.  Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability.

Authors:  Claudia Giannavola; Claudio Bucolo; Adriana Maltese; Donatella Paolino; Maria Angela Vandelli; Giovanni Puglisi; Vinecent H L Lee; Massimo Fresta
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

8.  Preparation and ocular pharmacokinetics of ganciclovir liposomes.

Authors:  Yan Shen; Jiasheng Tu
Journal:  AAPS J       Date:  2007-12-07       Impact factor: 4.009

9.  Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.

Authors:  Soumyajit Majumdar; Tushar Hingorani; Ramesh Srirangam; Rama Sarma Gadepalli; John M Rimoldi; Michael A Repka
Journal:  Pharm Res       Date:  2008-10-07       Impact factor: 4.200

10.  Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.

Authors:  Hanan Refai; Doaa Hassan; Rehab Abdelmonem
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.